CCR Vaccine Branch FACS Core
|
Research Initiative
|
FDA
|
NCI
|
|
|
CCR, LGI, Flow Cytometry Core
|
Research Initiative
|
FDA
|
NCI
|
|
|
CDC Pathogen Genomic Centers of Excellence (PGCoE)
|
Research Initiative
|
CDC
|
NIAID
|
2022
|
|
Cell-Surface Interactions in Pathogenesis
|
Research Initiative
|
FDA
|
NIDCR
|
|
|
Central Brain Tumor Registry of the United States (CBTRUS)
|
Research Initiative
|
CDC
|
|
2021
|
|
CFAR Diversity, Equity, Inclusion Pipeline Initiative (CDEIPI)
|
Research Initiative
|
OASH
|
NIAID, NIMH, NCI, NHLBI, NIDDK, NINR, NIDCR, NIMHD, NICHD, NIA, FIC, OD/ DPCPSI/ OAR
|
2021
|
|
Circulating Estrogens, Androgens, and Progestogens and Risk of Breast Cancer in the PLCO Cohort
|
Research Initiative
|
CDC
|
|
2018
|
|
CLARITY - Mammary Gland efforts
|
Research Initiative
|
ATSDR
|
NIEHS
|
2016
|
|
Clinical Trials of Biodefense Vaccines (Dengue)
|
Research Initiative
|
CDC
|
NIAID
|
|
|
Combined Exposures and Mixtures Research Program
|
Research Initiative
|
ATSDR, CDC, FDA, OASH
|
NIEHS
|
|
|
Computational Toxicology for NIH Medications Discovery
|
Research Initiative
|
FDA
|
NIDA
|
2000
|
|
Computer-aided Diagnosis for Radiology Images
|
Research Initiative
|
FDA
|
CC, OD/ OIR
|
2004
|
|
Consumer Product Chemical Exposures in Pregnancy and Their Cumulative Impact on Disorders of Fetal Growth
|
Research Initiative
|
CDC
|
|
2020
|
|
Coordinating Committee on Research on Women's Health (CCRWH) Sex, Gender, and Intersectionality (SG&I) Innovations Working Group (CCRWH SG&I Innovations WG)
|
Research Initiative
|
FDA, AHRQ, Other
|
OD, NIA, NHLBI, OD/ AoU, NIGMS, NICHD, NCI, NINDS, NIBIB, NCCIH, NIDA
|
2022
|
|
Countermeasures Against Chemical Threats program (CounterACT)
|
Research Initiative
|
ASPR
|
NIAID, NIAMS, NICHD, NEI, NINDS, NIDA
|
2006
|
|
Country Work in Cancer Research and Cancer Control Planning Strengthening – Kenya
|
Research Initiative
|
CDC
|
FIC, NIAID
|
2013
|
|
COVID-19 and Influenza Scenario Modeling Hubs (SMH)
|
Research Initiative
|
CDC
|
NIGMS
|
2020
|
|
CURE ID App for Infectious Disease Case Reporting
|
Research Initiative
|
FDA
|
NCI
|
|
|